Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | LPL | P06858 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6194233 | 0.97 | IDO1 (0.41) | IDO1DAOCNR1CNR2TRPV1 | |
| SCHEMBL14473767 | 0.94 | CNR1 (0.38) | IDO1DAOCNR1CNR2TRPV1 | |
| SCHEMBL16958903 | 0.85 | FFAR4 (0.39) | IDO1CNR1CNR2PTGS2PTGS1 | |
| SCHEMBL8990727 | 0.85 | CYP17A1 (0.56) | CNR1CNR2CYP17A1CYP21A2CYP11B1 | |
| SCHEMBL28019926 | 0.85 | IDO1 (0.38) | IDO1DAOCNR1CNR2TRPV1 | |
| SCHEMBL4197444 | 0.84 | NPC1 (0.50) | IDO1TRPV1CA1PTGS2CYP3A4 | |
| SCHEMBL16955785 | 0.84 | CYP4F2 (0.46) | CNR1CNR2TRPV1PTGS2CYP3A4 | |
| SCHEMBL5411709 | 0.84 | POLB (0.33) | IDO1DAOCNR1CNR2TRPV1 | |
| SCHEMBL13349208 | 0.84 | DAO (0.39) | IDO1DAOCNR1CNR2CYP17A1 | |
| SCHEMBL16958901 | 0.84 | CNR1 (0.32) | IDO1DAOCNR1CNR2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119792995-A | Extraction liquid for extracting lithium ion battery electrolyte and extraction method of lithium ion battery electrolyte | 江苏正力新能电池技术股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-101768447-B | Polyfluoric terphenyl liquid crystal compound and synthesis method and use thereof | SHIJIAZHUANG YONGSHENG HUATSING LIQUID CRYSTAL CO LTD | 2013-08-14 | — | — | CN | claimed |
| WO-2025092096-A1 | COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 华为技术有限公司 | 2025-05-08 | — | — | WO | disclosed |
| CN-119912473-A | Compound and preparation method and application thereof | 华为技术有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119792995-A | Extraction liquid for extracting lithium ion battery electrolyte and extraction method of lithium ion battery electrolyte | 江苏正力新能电池技术股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-20240217963-A1 | RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-07-04 | — | — | US | disclosed |
| US-20240004296-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
| US-20230312587-A1 | PTERIDINONE COMPOUNDS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED | 2023-10-05 | — | — | US | disclosed |
| US-20230303562-A1 | PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-09-28 | — | — | US | disclosed |
| CN-113874420-B | Resin film and metal-clad laminate | 日铁化学材料株式会社 | 2023-09-26 | — | — | CN | disclosed |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | SCHERING CORPORATION | 2007-08-16 | — | — | US | disclosed |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-07-12 | — | — | US | disclosed |
| US-20070032531-A1 | SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2007-02-08 | — | — | US | disclosed |
| US-20070021331-A1 | Methods of using macrocyclic modulators of the ghrelin receptor | TRANZYME PHARMA INC. | 2007-01-25 | — | — | US | disclosed |
| US-5800734-A | 1-fluorocyclohexene-difluorophenyl derivatives | ROLIC AG (CH) | 1998-09-01 | — | — | US | disclosed |
| EP-0598354-B1 | Fluor substituted tolan derivatives and liquid crystals mixtures containing them | MERCK PATENT GMBH (DE) | 1997-04-09 | — | — | EP | disclosed |
| US-5582767-A | Fluorosubstituted tolane derivatives | HOFFMANN-LA ROCHE INC. (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0736513-A1 | 1-Fluorcyclohexene-difluorphenyl derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1996-10-09 | — | — | EP | disclosed |
| EP-0598354-A1 | Fluor substituted tolan derivatives and liquid crystals mixtures containing them | F. HOFFMANN-LA ROCHE AG (CH) | 1994-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303562-A1 | PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | CYP51A1, CYP4F11, WEE1 | IDO1 1056/4885DAO 4312/4885CNR1 1874/4885 |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | CETP, CES1, NPC1 | IDO1 4374/4885DAO 4682/4885CNR1 287/4885 |
| US-20070032531-A1 | SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE | SPHK1, SPHK2, S1PR2 | IDO1 2639/4885DAO 3290/4885CNR1 1246/4885 |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | MAPK1, MAPK4, MAPKAPK2 | IDO1 2606/4885DAO 4108/4885CNR1 2910/4885 |
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | OCIAD1, OCIAD2, SLCO4C1 | IDO1 3050/4885DAO 2480/4885CNR1 3973/4885 |
| US-20070021331-A1 | Methods of using macrocyclic modulators of the ghrelin receptor | GHSR, GHRHR, GIPR | IDO1 3963/4885DAO 3976/4885CNR1 166/4885 |
| US-20230312587-A1 | PTERIDINONE COMPOUNDS AND USES THEREOF | DPYD, PKD1, TYMP | IDO1 952/4885DAO 1329/4885CNR1 2459/4885 |
| US-20240217963-A1 | RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF | RIPK1, RIPK2, RIPK4 | IDO1 3677/4885DAO 4484/4885CNR1 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.